- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 14.82M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 14.9M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 14.27M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $358.94K |
| Capex | Q1 2026 · Mar 31, 2025 | $451.73K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.59M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$366.91K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $12.16M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $10.02M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $13.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $13.47M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $10.58M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $14.29M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $7.84M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $9.22M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $23.24M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $24.87M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.13 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.9M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.26M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.88M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.77M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $3.66M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $21.09M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $4.26M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $5.62M |